SCHEMBL17212928

SCHEMBL17212928

Cc1cccc(/C=C\CN)c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.36
TRPA1 O75762 1/20 0.35
ATM Q13315 1/20 0.35
HTR2A P28223 2/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
TSHR P16473 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PTGER1 P34995 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGER3 P43115 1/20 0.34
PTGER2 P43116 1/20 0.34
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAPT P10636 2/20 0.32
CD44 P16070 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085821 0.83 ALDH1A1 (0.46) TAAR1TSHRALDH1A1PTGER1PTGER4
SCHEMBL12426100 0.83 ALDH1A1 (0.46) TAAR1TSHRALDH1A1PTGER1PTGER4
SCHEMBL4441030 0.82 TRPA1 (0.37) TRPA1ATMTSHRALDH1A1PTGER1
SCHEMBL6546426 0.80 TRPA1 (0.46) TRPA1ATMTSHRALDH1A1CD44
SCHEMBL4318496 0.80 TRPA1 (0.46) TRPA1ATMTSHRALDH1A1CD44
SCHEMBL10896772 0.80 TRPA1 (0.35) TRPA1ATMTSHRALDH1A1PTGER1
SCHEMBL2095465 0.80 ALDH1A1 (0.39) TRPA1ATMHTR2CTSHRALDH1A1
SCHEMBL4630319 0.80 TRPA1 (0.35) TRPA1ATMTSHRALDH1A1PTGER1
SCHEMBL2095468 0.80 ALDH1A1 (0.39) TRPA1ATMHTR2CTSHRALDH1A1
SCHEMBL27994690 0.80 TRPA1 (0.40) TRPA1ATMTSHRALDH1A1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9546174-B2 Inhibitor of apoptosis protein (IAP) antagonists SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2017-01-17 US disclosed
US-20150307499-A1 INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307499-A1 INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS API5, XIAP, BIRC5 TAAR1 4428/4885TRPA1 3617/4885ATM 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.